CIBC World Market’s NeoGenomics NEO Stock Holding History

CIBC World Market’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,875	Closed	-$213K	–	1139
2020 Q2	$213K	Sell	6,875 -24,505	-78%	-$679K	﹤0.01%	997
2020 Q1	$866K	Buy	+31,380	New	+$940K	﹤0.01%	576

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIBC World Market's NEO Position: Q3 2020 in Review

CIBC World Market sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 6,875 shares — an estimated $213K sold.

CIBC World Market first reported a position in NEO in Q1 2020 and held it in 2 quarters. The position peaked at $866K in Q1 2020. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

CIBC World Market reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
CIBC World Market sold 6,875 NeoGenomics shares in Q3 2020, an estimated $213K.
CIBC World Market first reported a position in NeoGenomics in Q1 2020 and held it in 2 quarters.
CIBC World Market's NeoGenomics position peaked at $866K in Q1 2020.
294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on CIBC World Market's 13F filing for Q3 2020, filed 12 Nov 2020.